Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) in prostate cancer: PSMA-RADS classification and PROMISE criterias

被引：0
|
作者：
Robin, P. [1 ,2 ,5 ]
Palard-Novello, X. [3 ,4 ]
Bailly, C.
机构：
[1] Ctr Hosp Univ Brest, Serv Med Nucl, 2 Ave Foch, F-29269 Brest, France
[2] Univ Brest, CHU Brest, UMR 1304, Inserm, Brest, France
[3] Univ Rennes, CLCC Eugene Marquis, INSERM, LTSI UMR 1099, Ave Bataille Flandres Dunkerque, F-35042 Rennes, France
[4] Ctr Hosp Univ Nantes, Serv Med Nucl, Nantes, France
[5] Univ Brest, Ctr Hosp & Univ Brest, Inserm, UMR 1304,CHRU Brest,GETBO,Serv Med Nucl, 2 Ave Foch, F-29609 Brest, France
来源：
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2023年 / 47卷 / 05期
关键词：
Positron emission tomography; Prostate specific membrane antigen; receptor; Prostate cancer; Classifications; VERSION; PEARLS; EANM;
D O I：
10.1016/j.mednuc.2023.07.005
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) is nowadays widely used for the management of patients with prostate cancer during natural history of the disease. PSMA is not specific to prostate tissue, many benign and malignant diseases unrelated to prostate cancer are frequently found on PSMA-PET examinations, leading to false positives results and potentially to inadequate patient management. Various interpretation criteria have been proposed within classifications in order to standardize and homogenize PSMA-PET interpretation. This article describes, on the one hand the PSMA-RADS classification, and on the other hand the PROMISE criteria. (c) 2023 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码：270 / 275
页数：6
相关论文
共 50 条
  • [41] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Perner, SR
    Hofer, MD
    Li, H
    Kuefer, R
    Gschwend, J
    Hautmann, R
    Moeller, P
    Rubin, MA
    LABORATORY INVESTIGATION, 2006, 86 : 155A - 155A
  • [42] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Michael Sun
    Muhammad Junaid Niaz
    Muhammad Obaid Niaz
    Scott T. Tagawa
    Current Oncology Reports, 2021, 23
  • [43] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Sun, Michael
    Niaz, Muhammad Junaid
    Niaz, Muhammad Obaid
    Tagawa, Scott T.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (05)
  • [44] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Perner, SR
    Hofer, MD
    Li, H
    Kuefer, R
    Gschwend, J
    Hautmann, R
    Moeller, P
    Rubin, MA
    MODERN PATHOLOGY, 2006, 19 : 155A - 155A
  • [45] The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy
    Amit, U.
    Goldstein, J. D.
    Davidson, T.
    Hahiashvili, M.
    Goshen, E.
    Oksman, Y.
    Berger, R.
    Saad, A.
    Sadetsky, I.
    Chikman, B.
    Lawrence, Y. R.
    Ben-Haim, S.
    Symon, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S112 - S113
  • [46] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Hofer, MD
    Perner, S
    Li, HJ
    Kuefer, R
    Hautmann, RE
    Gschwend, JE
    Moeller, P
    Rubin, MA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 155 - 156
  • [47] Advances in Prostate-Specific Membrane Antigen (PSMA)-Targeted Phototheranostics of Prostate Cancer
    Wang, He
    He, Zhangxin
    Liu, Xiao-Ang
    Huang, Yuhua
    Hou, Jianquan
    Zhang, Weijie
    Ding, Dan
    SMALL STRUCTURES, 2022, 3 (08):
  • [48] Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer
    Afshar-Oromieh, A.
    Alberts, I.
    Sachpekidis, C.
    Rominger, A.
    UROLOGE, 2019, 58 (12): : 1429 - 1434
  • [49] Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
    Sheikhbahaei, Sara
    Werner, Rudolf A.
    Solnes, Lilja B.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 255 - 270
  • [50] Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody
    Nagaya, Tadanobu
    Nakamura, Yuko
    Okuyama, Shuhei
    Ogata, Fusa
    Maruoka, Yasuhiro
    Choyke, Peter L.
    Kobayashi, Hisataka
    MOLECULAR CANCER RESEARCH, 2017, 15 (09) : 1153 - 1162
12345